5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.54%
Positive revenue growth while STERV.HE is negative. John Neff might see a notable competitive edge here.
-5.90%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-8.41%
Negative EBIT growth while STERV.HE is at 19.72%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-8.41%
Negative operating income growth while STERV.HE is at 19.72%. Joel Greenblatt would press for urgent turnaround measures.
-10.47%
Negative net income growth while STERV.HE stands at 18.64%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-8.60%
Negative EPS growth while STERV.HE is at 12.50%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-8.60%
Negative diluted EPS growth while STERV.HE is at 12.50%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-2.06%
Share reduction while STERV.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.06%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-100.00%
Dividend reduction while STERV.HE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
42.67%
Positive OCF growth while STERV.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
99.25%
Positive FCF growth while STERV.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-29.49%
Negative 10Y revenue/share CAGR while STERV.HE stands at 6.20%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-4.39%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
16.34%
3Y revenue/share CAGR above 1.5x STERV.HE's 0.38%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-41.77%
Negative 10Y OCF/share CAGR while STERV.HE stands at 103.09%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-14.26%
Negative 5Y OCF/share CAGR while STERV.HE is at 123.94%. Joel Greenblatt would question the firm’s operational model or cost structure.
-31.60%
Negative 3Y OCF/share CAGR while STERV.HE stands at 26.81%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
138.09%
Net income/share CAGR 1.25-1.5x STERV.HE's 113.47%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
56.90%
Positive 5Y CAGR while STERV.HE is negative. John Neff might view this as a strong mid-term relative advantage.
82.83%
Positive short-term CAGR while STERV.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
52.58%
5Y equity/share CAGR above 1.5x STERV.HE's 31.18%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.39%
3Y equity/share CAGR above 1.5x STERV.HE's 22.24%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.70%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-3.27%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.08%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
3.61%
BV/share growth above 1.5x STERV.HE's 2.02%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.14%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-12.62%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.